ArticleJournal of thoracic disease2026
Perioperative outcomes and quality of life after minimally invasive versus median sternotomy left ventricular assist device implantation: a single-center retrospective cohort study.
Article in Journal of thoracic disease, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
12 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Left ventricular assist device (LVAD) implantation is an effective destination therapy (DT) for patients ineligible for heart transplantation. While conventional median sternotomy (MS) is widely used, it involves significant surgical trauma, bleeding risk, and delayed recovery, potentially hindering rehabilitation. Minimally invasive (MI) techniques may reduce perioperative complications and enhance long-term quality of life. However, systematic comparisons between MI and MS approaches for LVAD implantation are limited, with scarce data from Chinese populations. This study compares perioperative outcomes, functional recovery, and health-related quality of life between these surgical approaches, providing high-level evidence to inform clinical practice. Methods: This study included 18 patients who underwent LVAD implantation (MI, n=12; MS, n=6). Preoperative characteristics, intraoperative metrics, postoperative recovery parameters, and complication rates were collected and compared between the two groups. Postoperative quality of life was evaluated with a comprehensive scale integrating generic health status, disease-specific symptoms, and device-related distress. Results: The MI group demonstrated superior perioperative outcomes. Intraoperative blood loss was reduced by nearly 50% (442.5±257.7 Conclusions: MI LVAD implantation is as safe as MS. It maintains equivalent cardiac improvement while offering faster recovery and enhanced postoperative quality of life.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.